Thomas van Doeveren
Papers
2
Total Citations
38
H-Index
2
About
Thomas van Doeveren is a rising surgical oncologist whose research is reshaping the surgical management of urologic cancers, with a particular focus on upper tract urothelial carcinoma (UTUC) and bladder cancer. His work centers on comparing the oncological and perioperative outcomes of different surgical approaches—open, laparoscopic, and robotic—to determine the safest and most effective techniques for patients. In a landmark 2023 multicenter, multinational study, van Doeveren led a propensity score-matched analysis of over 1,000 patients undergoing radical nephroureterectomy for UTUC. This work, which has already garnered 30 citations, provided critical evidence that robotic and laparoscopic approaches offer comparable oncological safety to open surgery while potentially reducing perioperative morbidity. His 2021 investigation into robot-assisted versus open radical cystectomy for muscle-invasive bladder cancer further demonstrated his commitment to advancing minimally invasive surgery, showing non-inferior intermediate-term survival outcomes in a Dutch national cohort. By leveraging large-scale, real-world data and rigorous statistical methods, van Doeveren is helping to define evidence-based surgical standards that balance cancer control with quality of life. His contributions are particularly valuable for young surgeons and researchers seeking to understand the evolving landscape of robotic urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2